MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer

Author: Paule Bernard  

Publisher: Humana Press, Inc

ISSN: 1357-0560

Source: Medical Oncology, Vol.27, Iss.4, 2010-12, pp. : 1066-1072

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content